HIGHLIGHTS
- who: Yi Zhang from the State Key LaboratoryTong University, Guangzhou, China have published the research work: Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer, in the Journal: (JOURNAL)
- what: Illuminated by current study, the authors propose the following paradigm shift toward precision immunotherapy for cervical cancer.
- how: The study was conducted in accordance with ethical guidelines of the U.S. Common Rule and was approved by the Ethics Committee of Ren Ji Hospital. Taken together these results indicated that cervical cancer at baseline contained both innate and adaptive immune . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.